Pieter Jelle Visser
Department of Neurology
Alzheimer Centre
VU Medisch Centrum
Amsterdam
Netherlands
Name/email consistency: high
- Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients. Visser, P.J., Scheltens, P., Pelgrim, E., Verhey, F.R. Dement. Geriatr. Cogn. Disord (2005)